Tyra Biosciences Inc
Ownership
Ownership Structure
Who owns Tyra Biosciences Inc (TYRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.3% of the shares are freely tradable; institutional investors hold 111.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 20.44 | 12,198,625 | +0.0 | 03/31/2026 |
| FMR Inc | 12.98 | 7,747,648 | +61,570.4 | 03/31/2026 |
| HHG PLC | 6.52 | 3,890,589 | +32.5 | 03/31/2026 |
| Alta Partners Management Company, L.P. | 6.41 | 3,823,425 | +0.0 | 06/30/2026 |
| Farallon Capital Management, L.L.C. | 6.00 | 3,580,818 | +73.3 | 03/31/2026 |
| Nextech Invest, Ltd. | 5.95 | 3,553,585 | -12.4 | 06/30/2026 |
| TCG Crossover Management, LLC | 5.44 | 3,248,980 | +0.0 | 06/30/2026 |
| COMMODORE CAPITAL LP | 4.15 | 2,475,000 | -26.7 | 03/31/2026 |
| BlackRock Inc | 3.72 | 2,217,929 | +6.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity OTC | 5.52 | 3,295,446 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Verjee Rehan | Director | 972 | 23,714 $ | Sep 9, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Verjee Rehan | Director | Buy | 972 | 20.58 | 20,002 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.